Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell.

Boozer S, Lehman N, Lakshmipathy U, Love B, Raber A, Maitra A, Deans R, Rao MS, Ting AE.

J Stem Cells. 2009;4(1):17-28. doi: jsc.2009.4.1.17.

PMID:
20498688
2.

Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.

Plessers J, Dekimpe E, Van Woensel M, Roobrouck VD, Bullens DM, Pinxteren J, Verfaillie CM, Van Gool SW.

Stem Cells Transl Med. 2016 Dec;5(12):1607-1619. Epub 2016 Jul 27.

4.

Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow.

Subramanian K, Geraerts M, Pauwelyn KA, Park Y, Owens DJ, Muijtjens M, Ulloa-Montoya F, Jiang Y, Verfaillie CM, Hu WS.

Methods Mol Biol. 2010;636:55-78. doi: 10.1007/978-1-60761-691-7_4.

PMID:
20336516
5.

Culturing protocols for human multipotent adult stem cells.

Vaes B, Walbers S, Gijbels K, Craeye D, Deans R, Pinxteren J, van't Hof W.

Methods Mol Biol. 2015;1235:49-58. doi: 10.1007/978-1-4939-1785-3_5.

PMID:
25388385
6.

Development of a surrogate angiogenic potency assay for clinical-grade stem cell production.

Lehman N, Cutrone R, Raber A, Perry R, Van't Hof W, Deans R, Ting AE, Woda J.

Cytotherapy. 2012 Sep;14(8):994-1004. doi: 10.3109/14653249.2012.688945. Epub 2012 Jun 11.

PMID:
22687190
7.
8.

Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells.

Kovacsovics-Bankowski M, Mauch K, Raber A, Streeter PR, Deans RJ, Maziarz RT, Van't Hof W.

Cytotherapy. 2008;10(7):730-42. doi: 10.1080/14653240802320245.

PMID:
18985479
9.

Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.

Jacobs SA, Pinxteren J, Roobrouck VD, Luyckx A, van't Hof W, Deans R, Verfaillie CM, Waer M, Billiau AD, Van Gool SW.

Cell Transplant. 2013;22(10):1915-28. doi: 10.3727/096368912X657369. Epub 2012 Oct 1.

PMID:
23031260
10.

Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial.

Maziarz RT, Devos T, Bachier CR, Goldstein SC, Leis JF, Devine SM, Meyers G, Gajewski JL, Maertens J, Deans RJ, Van't Hof W, Lazarus HM.

Biol Blood Marrow Transplant. 2015 Apr;21(4):720-8. doi: 10.1016/j.bbmt.2014.12.025. Epub 2014 Dec 30.

11.

Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells.

Larson BL, Ylostalo J, Lee RH, Gregory C, Prockop DJ.

Tissue Eng Part A. 2010 Nov;16(11):3385-94. doi: 10.1089/ten.tea.2010.0085. Epub 2010 Jul 13.

12.

Multipotent adult progenitor cells from swine bone marrow.

Zeng L, Rahrmann E, Hu Q, Lund T, Sandquist L, Felten M, O'Brien TD, Zhang J, Verfaillie C.

Stem Cells. 2006 Nov;24(11):2355-66. Epub 2006 Aug 24. Erratum in: Stem Cells. 2007 Sep;25(9):2387.

13.

Multipotent Adult Progenitor Cells from Bone Marrow Differentiate into Chondrocyte-Like Cells.

Yu L, Weng Y, Shui X, Fang W, Zhang E, Pan J.

J Arthroplasty. 2015 Jul;30(7):1273-6. doi: 10.1016/j.arth.2015.01.037. Epub 2015 Jan 31.

PMID:
25703771
14.

In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells.

Muguruma Y, Reyes M, Nakamura Y, Sato T, Matsuzawa H, Miyatake H, Akatsuka A, Itoh J, Yahata T, Ando K, Kato S, Hotta T.

Exp Hematol. 2003 Dec;31(12):1323-30. Erratum in: Exp Hematol. 2008 Aug;36(8):1055.

PMID:
14662341
15.

Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency.

Lee WC, Shi H, Poon Z, Nyan LM, Kaushik T, Shivashankar GV, Chan JK, Lim CT, Han J, Van Vliet KJ.

Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4409-18. doi: 10.1073/pnas.1402306111. Epub 2014 Oct 8.

16.

Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells.

Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K, Atkinson K.

Stem Cells Dev. 2008 Dec;17(6):1095-107. doi: 10.1089/scd.2007.0154.

PMID:
19006451
17.

Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction.

Lodie TA, Blickarz CE, Devarakonda TJ, He C, Dash AB, Clarke J, Gleneck K, Shihabuddin L, Tubo R.

Tissue Eng. 2002 Oct;8(5):739-51.

PMID:
12459053
18.

Multipotent adult progenitor cells: an update.

Verfaillie CM.

Novartis Found Symp. 2005;265:55-61; discussion 61-5, 92-7. Review.

PMID:
16050250
19.

Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum.

Dahl JA, Duggal S, Coulston N, Millar D, Melki J, Shahdadfar A, Brinchmann JE, Collas P.

Int J Dev Biol. 2008;52(8):1033-42. doi: 10.1387/ijdb.082663jd.

20.

Isolation and culture of rodent bone marrow-derived multipotent mesenchymal stromal cells.

Nardi NB, Camassola M.

Methods Mol Biol. 2011;698:151-60. doi: 10.1007/978-1-60761-999-4_12.

PMID:
21431517

Supplemental Content

Support Center